-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:伦诺克斯公司公布第一季度调整后每股收益为3.35美元,同比下降0.6%,但超出市场预期0.17美元。销售额增长6%至11.4亿美元(比预期高出6400万美元),主要得益于已完成的收购。家居舒适解决方案业务环比有所改善,收入同比下降10%,而去年同期为21%。但由于通胀压力,该业务的利润率下降了390个基点至13.3%。建筑气候解决方案业务实现了强劲的内生增长,增幅达26%,利润率提升300个基点至约19.7%,这主要得益于新赢得的全国性客户以及紧急更换业务的强劲表现。管理层维持全年每股收益预期在23.50美元至25.00美元之间,同时将收入增长预期从之前的6.5%中值上调至约8%。受持续的库存正常化调整支持,经营现金流显著改善,从上年同期的负3600万美元增至1600万美元。我们认为,公司能够维持7.5亿美元至8.5亿美元的自由现金流预期,体现了其对在住宅市场短期运营挑战下创造强劲现金回报的信心。
Related Articles
Sysco Extends Q3 Momentum, Calms Restaurant Depot Concerns, UBS Says
Sysco's (SYY) momentum in fiscal Q3 remained intact as the company pushed back on concerns that its pending Jetro Restaurant Depot acquisition would require a costly overhaul, UBS Securities said Wednesday in a report.UBS said Sysco continued to post steady operational gains in the period, including its strongest US growth in case shipments to independent restaurants since Q3 2023. Questions around Restaurant Depot's condition may linger, though Sysco's third-party inspections of more than 160 stores helped ease investor concerns, the report said.International results also improved, and UBS expects that business to keep benefiting from supply-chain and private-label investments. Still, higher energy costs in Europe could pressure consumers if the Middle East conflict drags on, the report said.UBS maintained its buy rating on Sysco stock with a price target of $90.Price: $73.79, Change: $+0.42, Percent Change: +0.57%
Research Alert: CFRA Lowers Rating On Alexandria Real Estate Equities, Inc. To Sell From Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We decrease our 12-month target by $29 to $35, a forward P/FFO of 6.1x our 2027 FFO estimate, a discount to ARE's one-year average (7.6x) due to negative re-leasing rates, planned asset sales, and a slowdown in leasing. We see 2027 revenue 17.8% lower than 2025 based on property sales/declining rents. We lower our 2026 FFO estimate by $0.26 to $6.27 and 2027's by $0.41 to $5.74. We now believe management has no visibility into re-leasing and occupancy trends even for 2H 2026 given the larger-than-expected decline in Q1 (-15.8% vs -5.2% in Q4 2026). While management believes AI will not replace physical labs, it could compress timelines and slow re-leasing in the near term. Management perceives the lifting of the 15% NIH limitation on reimbursement of indirect costs as a big win, but we do not anticipate this creating new demand in the near term. We also note that there is 1.5M sqft of lease expirations in 2027 that management now believes will have downtime negatively impacting 2027 by $97 million.
On Holding Likely to Post Q1 Sales Beat on Solid Trends, UBS Says
On Holding (ONON) is likely to post Q1 sales growth beat and raise its 2026 guidance on solid topline trends, UBS said in a Wednesday research report. The company is due to release Q1 results on May 12.The sentiment around the stock appears bearish amid the recent CEO change as well as high oil prices weighing much more on its margin guidance than expected, analysts wrote.Channel checks indicated that the company's Q1 digital trends were solid with total and unique global visits to its site rising 20% and 21%, respectively, while European Union spend likely grew 35%, according to the note.For Q1, UBS expects sales growth of 15.4%, but forex remains a material headwind, according to the note. For 2026, the brokerage said it expects the company to raise its sales growth guidance by 100 basis points.The brokerage maintained its buy rating on the stock and price target of $85 per share.Price: $34.95, Change: $-0.48, Percent Change: -1.35%